ADVANZ PHARMA acquires Testoviron® rights from Bayer in Europe and parts of LATAM, MEA, and APAC
Overview
ADVANZ PHARMA Holdco Limited, a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines across Europe, Canada, and Australia, has completed the purchase of the commercial rights to Testoviron® from Bayer for Europe and selected markets in Latin America, the Middle East & Africa, and Asia-Pacific.
The injectable testosterone: Testoviron
• Testoviron® is a long-acting injectable testosterone used to treat male hypogonadism*.
• Adding the brand strengthens ADVANZ PHARMA’s specialty portfolio and leverages its commercial and medical operations in Europe and global partner network.
• The transaction builds on existing agreements between ADVANZ PHARMA and Bayer.
• Financial terms are not being disclosed.
*Indications vary by market, strength, and form. For local indications please check the local approved label.
About ADVANZ PHARMA
• Partner of choice in specialty, hospital, and rare disease medicines.
• ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing and enhancing the specialty, hospital, and rare disease medicines they depend on.
• Our headquarters are in London, UK.
• We have commercial sales in more than 90 countries globally and have a direct commercial presence in more than 20 countries, including key countries in Europe, the US, Canada, and Australia, a Centre of Excellence in Mumbai, India, as well as an established global distribution and commercialisation partner network.
• ADVANZ PHARMA’s product portfolio and pipeline comprises innovative medicines, biosimilars & specialty generics, and originator brands.
• Our products cover a broad range of therapeutic areas, including hepatology, rheumatology, gastroenterology, anti-infectives, critical care, endocrinology, oncology, CNS, and, more broadly, rare disease medicines.
• Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia.
• In line with our ambition, we are partnering with biopharma and development companies to bring medicines to patients.
• We can only achieve this due to our dedicated and highly qualified employees, acting in line with our company values of entrepreneurship, speed, and integrity.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!